Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

37.59
+0.14000.37%
Post-market: 37.590.00000.00%19:30 EDT
Volume:429.25K
Turnover:16.16M
Market Cap:3.62B
PE:-19.22
High:38.27
Open:37.74
Low:37.24
Close:37.45
52wk High:42.68
52wk Low:24.24
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.75
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.02
PE(LYR):-29.25

Loading ...

IDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained

TIPRANKS
·
Jul 27

Ideaya Biosciences initiates monotherapy expansion in IDE892 trial

TIPRANKS
·
Jul 27

Ideaya Begins Phase 1/2 Part 2 Monotherapy Expansion of Ide892 in MTAP-deleted Pancreatic, Lung Cancers

Reuters
·
Jul 27

Ideaya Biosciences Announces Ide892, a Potential Best-in-Class Mta-Cooperative Prmt5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in Mtap-Deleted Pancreatic and Lung Cancers

THOMSON REUTERS
·
Jul 27

Ideaya Shares ESMO 2026 Data Updates for Darovasertib Trials in Uveal Melanoma

Reuters
·
Jul 17

Ideaya Biosciences Chief Accounting Officer Andres Ruiz Briseno Sells 9,550 Shares for $382,131.94

Reuters
·
Jul 10

Ideaya Biosciences price target lowered to $63 from $65 at Truist

TIPRANKS
·
Jul 07

Ideaya Biosciences is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

RBC Capital Adjusts IDEAYA Biosciences Price Target to $48 From $53, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Ideaya Biosciences Grants Inducement Stock Options for 98,000 Shares at $36.29 Each

Reuters
·
Jun 26

Ideaya Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jun 26

IDEAYA Biosciences Shareholders Back Leadership, Governance Changes

TIPRANKS
·
Jun 24

IDEAYA Biosciences shareholders ratified PwC as auditor for 2026

Reuters
·
Jun 24

Ideaya Biosciences elects CEO Yujiro Hata as chairman

TIPRANKS
·
Jun 17

IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of Its Board of Directors

THOMSON REUTERS
·
Jun 17

IDEAYA Biosciences - Terry Rosen to Serve as Lead Independent Director

THOMSON REUTERS
·
Jun 17

Press Release: IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors

Dow Jones
·
Jun 17

Is IDEAYA Biosciences (IDYA) Quietly Reframing Its MTAP Strategy With the New IDE892 Combinations?

Simply Wall St.
·
Jun 16

IDEAYA Biosciences' Phase 1 Clinical Trial of Lung, Pancreatic Cancer Treatment Enrolls First Patient

MT Newswires Live
·
Jun 15

Ideaya Biosciences enrolls first patient in IDE892 trial

TIPRANKS
·
Jun 15